Expense not allocated to segments.

No definition available.

Name:	jnj_ExpenseNotAllocatedToSegments
Namespace Prefix:	jnj_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(12))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(11))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

+ Details

Name:	us-gaap_Assets
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3602-108585

+ Details

Name:	us-gaap_DepreciationDepletionAndAmortization
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h)(1)(i))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

+ Details

Name:	us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Amount of acquisition of long-lived, physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.

+ References

No definition available.

+ Details

Name:	us-gaap_PropertyPlantAndEquipmentAdditions
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1)
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688

+ Details

Name:	us-gaap_Revenues
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Aggregate revenue during the period from the sale of goods in the normal course of business, after deducting returns, allowances and discounts.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1(a))
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688

+ Details

Name:	us-gaap_SalesRevenueGoodsNet
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingInformationRevenueAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=jnj_ConsumerMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=us-gaap_OperatingSegmentsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=jnj_GeneralCorporateMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementGeographicalAxis=country_US
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementGeographicalAxis=jnj_InternationalMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Segments of Business and Geographic Areas - Schedule of Segment Reporting Information (Details) - USD ($) $ in Millions	3 Months Ended								12 Months Ended
	Dec. 31, 2017	Oct. 01, 2017	Jul. 02, 2017	Apr. 02, 2017	Jan. 01, 2017	Oct. 02, 2016	Jul. 03, 2016	Apr. 03, 2016	Dec. 31, 2017	Jan. 01, 2017	Jan. 03, 2016
Sales by segment of business
Sales to Customers	$ 20,195	$ 19,650	$ 18,839	$ 17,766	$ 18,106	$ 17,820	$ 18,482	$ 17,482	$ 76,450	$ 71,890	$ 70,074
Earnings before provision for taxes on income	2,560	4,790	4,748	5,575	4,324	5,281	4,904	5,294	17,673	19,803	19,196
Identifiable Assets	157,303				141,208				157,303	141,208
Additions to Property, Plant & Equipment									3,279	3,226	3,463
Depreciation and Amortization									5,642	3,754	3,746
Consumer
Sales by segment of business
Sales to Customers	3,540	3,356	3,478	3,228	3,432	3,261	3,419	3,195
Pharmaceutical
Sales by segment of business
Sales to Customers	9,681	$ 9,695	$ 8,635	$ 8,245	8,232	$ 8,400	$ 8,654	$ 8,178
Operating Segments
Sales by segment of business
Identifiable Assets	129,893				91,221				129,893	91,221
Additions to Property, Plant & Equipment									2,987	2,885	3,238
Depreciation and Amortization									5,306	3,422	3,433
Corporate, Non-Segment
Sales by segment of business
Less: Expense not allocated to segments									1,326	1,043	1,151
Corporate, Non-Segment \| General Corporate
Sales by segment of business
Identifiable Assets	27,410				49,987				27,410	49,987
Additions to Property, Plant & Equipment									292	341	225
Depreciation and Amortization									336	332	313
Operating Segments
Sales by segment of business
Sales to Customers									76,450	71,890	70,074
Earnings before provision for taxes on income									18,999	20,846	20,347
Operating Segments \| United States
Sales by segment of business
Sales to Customers									39,863	37,811	35,687
Operating Segments \| Consumer
Sales by segment of business
Total									13,602	13,307	13,507
Earnings before provision for taxes on income									2,524	2,441	1,787
Identifiable Assets	25,030				23,971				25,030	23,971
Additions to Property, Plant & Equipment									485	486	544
Depreciation and Amortization									674	608	559
Operating Segments \| Consumer \| United States
Sales by segment of business
Total									5,565	5,420	5,222
Operating Segments \| Consumer \| International
Sales by segment of business
Total									8,037	7,887	8,285
Operating Segments \| Pharmaceutical
Sales by segment of business
Total									36,256	33,464	31,430
Earnings before provision for taxes on income									11,083	12,827	11,734
Identifiable Assets	59,450				27,477				59,450	27,477
Additions to Property, Plant & Equipment									936	927	1,063
Depreciation and Amortization									2,416	886	929
Operating Segments \| Pharmaceutical \| United States
Sales by segment of business
Total									21,474	20,125	18,333
Operating Segments \| Pharmaceutical \| International
Sales by segment of business
Total									14,782	13,339	13,097
Operating Segments \| Medical Devices
Sales by segment of business
Total									26,592	25,119	25,137
Earnings before provision for taxes on income									5,392	5,578	6,826
Identifiable Assets	$ 45,413				$ 39,773				45,413	39,773
Additions to Property, Plant & Equipment									1,566	1,472	1,631
Depreciation and Amortization									2,216	1,928	1,945
Operating Segments \| Medical Devices \| United States
Sales by segment of business
Total									12,824	12,266	12,132
Operating Segments \| Medical Devices \| International
Sales by segment of business
Total									$ 13,768	$ 12,853	$ 13,005